Bongriv-35 Tablet 1's belongs to the class of medicines called bisphosphonates used to treat or prevent osteoporosis (weak and brittle bones) caused by menopause or taking steroids for a long time. Also, Bongriv-35 Tablet 1's is used to treat Paget’s disease of bone. Osteoporosis is a bone disease that weakens and thins bones by decreasing bone density, common in post-menopausal women.  As the density of bones decreases, they weaken and are more likely to break.

Bongriv-35 Tablet 1's contains Risedronic acid that works by binding to the bone tightly and preventing the removal of calcium by osteoclasts (a type of bone cell that destroys bone tissue). This prevents osteoclasts from breaking down the bone and keeps the bones strong and minimizes the risk of bones breaking.

Take Bongriv-35 Tablet 1's as prescribed by your doctor. You are advised to take Bongriv-35 Tablet 1's for as long as your doctor has prescribed it for you based on your medical condition. In some cases, you may experience headache, nausea, indigestion, stomach pain, cramps or discomfort, constipation, diarrhea, pain in the muscles, joints, or bones, feeling of fullness or bloating. Most of these side effects of Bongriv-35 Tablet 1's do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.

If you are allergic to Bongriv-35 Tablet 1's, any sugars, or any other medicines, please tell your doctor. Avoid taking Bongriv-35 Tablet 1's if you are pregnant or breastfeeding and consult a doctor. Bongriv-35 Tablet 1's is not recommended for children below 18 years as the safety and effectiveness were not established. Avoid taking Bongriv-35 Tablet 1's if you have hypocalcemia (low calcium levels in the blood) and severe kidney problems. Avoid drinking alcohol as heavy drinking may also cause bone loss. Avoid smoking as it may decrease bone mineral density and increase the risk of fractures. Bongriv-35 Tablet 1's may cause osteonecrosis of the jaw (ONJ) in some patients. Therefore, if you experience any problems with teeth or mouth such as loose teeth, swelling or pain, non-healing of sores, or discharge, consult your doctor and dentist as these might be signs of osteonecrosis of the jaw.

Risedronate (risedronate sodium) helps your bones stay as strong as possible. Bongriv-35 Tablet 1's is used to treat osteoporosis and Paget’s disease. In osteoporosis, risedronate slows down the cells that break down bone. This maintains bone density and makes your bones stronger and less likely to break. In Paget's disease of bone, risedronate reduces the abnormal bone turnover that this condition causes. This helps to reduce deformity and pain and makes your bones stronger and less likely to break.

If you are allergic to Bongriv-35 Tablet 1's,  or any other medicines, please tell your doctor. Avoid taking Bongriv-35 Tablet 1's if you are pregnant or breastfeeding and consult a doctor. Bongriv-35 Tablet 1's is not recommended for children below 18 years as the safety and effectiveness were not established. Avoid taking Bongriv-35 Tablet 1's if you have hypocalcaemia (low calcium levels in the blood) and severe kidney problems. Avoid drinking alcohol as heavy drinking may also cause bone loss. If you have parathyroid hormone abnormalities, lack of vitamin D, swelling, numbness or pain in the jaw, loose tooth, heavy jaw feeling or had  Barrett’s oesophagus (abnormal change in the cells lining the lower oesophagus), inform your doctor before taking Bongriv-35 Tablet 1's. Avoid smoking as it may decrease bone mineral density and increase the risk of fractures. Bongriv-35 Tablet 1's may cause osteonecrosis of the jaw (ONJ) in some patients. Therefore, if you experience any problems with teeth or mouth such as loose teeth, swelling or pain, non-healing of sores or discharge, consult your doctor and dentist as these might be signs of osteonecrosis of the jaw. Your doctor may prescribe calcium and vitamin D supplements if you do not take sufficient from your diet.